Las desigualdades raciales de la pandemia persisten en la distribución de las vacunas infobae.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infobae.com Daily Mail and Mail on Sunday newspapers.
J&J Covid Vaccine Distribution in Poor, Black Communities Raises Race Questions nbcdfw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcdfw.com Daily Mail and Mail on Sunday newspapers.
email article
Now that Johnson & Johnson has joined Pfizer and Moderna in having a COVID-19 vaccine authorized in the U.S., the question on many people s minds is: who gets which vaccine?
Much of the discussion has focused on the differing vaccine efficacy numbers for the three products: those given for the J&J vaccine are in the 70% range, versus more than 90% for Pfizer s and Moderna s.
But the Biden administration and independent public health specialists insist that those figures aren t strictly comparable and the public shouldn t pay much attention to them.
Johnson & Johnson s is not an inferior vaccine, and we should not talk about who shouldn t get it; we should talk about how we can immunize hard-to-get populations, said Sarah Long, MD, a pediatric diseases physician at Drexel University College of Medicine in Philadelphia and a member of the CDC s Advisory Committee on Immunization Practices (ACIP), during an emergency meeting of the committee Monday.